The company’s executive vice president called China one of the fastest-growing medical device markets. The acquisition brings a strong product portfolio and new products in trauma, spine and joint reconstruction.
More Articles on Devices:
24 Spine Devices Receive FDA 510(k) Clearance in October
Lawmakers Launch Opposition to Federal Medical Device Sales Tax
Tornier CEO Douglas Kohrs Retires as President, CEO
